A new TaqMan real-time PCR assay to detect Parachlamydia acanthamoebae and to monitor its co-existence with SARS-COV-2 among COVID-19 patients

[1]  N. Verma,et al.  Atypical bacterial co‐infections among patients with COVID‐19: A study from India , 2021, Journal of medical virology.

[2]  N. Verma,et al.  Coinfections with Other Respiratory Pathogens among Patients with COVID-19 , 2021, Microbiology spectrum.

[3]  Kirsty F. Smith,et al.  q-PCR-based assay for the toxic dinoflagellate Karenia selliformis monitoring along the Tunisian coasts , 2021, Environmental Science and Pollution Research.

[4]  Kirsty F. Smith,et al.  Development and application of a real-time PCR assay for the sensitive detection of diarrheic toxin producer Prorocentrum lima. , 2020, Journal of microbiological methods.

[5]  O. Bakare,et al.  Diagnostic approaches of pneumonia for commercial-scale biomedical applications: an overview , 2020 .

[6]  S. Abdelkafi,et al.  Development of a new TaqMan-based PCR assay for the specific detection and quantification of Simkania negevensis. , 2020, Molecular and cellular probes.

[7]  P. Palange,et al.  Co-infection of SARS-CoV-2 with Chlamydia or Mycoplasma pneumoniae: a case series and review of the literature , 2020, Infection.

[8]  Sreedhar Adapa,et al.  Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID‐19 and Mycoplasma pneumoniae in the USA , 2020, Journal of medical virology.

[9]  W. Lim,et al.  Co-infections in people with COVID-19: a systematic review and meta-analysis , 2020, Journal of Infection.

[10]  J. Redón,et al.  Co‐detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease‐2019 pneumonia , 2020, Journal of medical virology.

[11]  N. Shah,et al.  Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens. , 2020, JAMA.

[12]  G. Barlow,et al.  Sixty‐eight consecutive patients assessed for COVID‐19 infection: Experience from a UK Regional infectious diseases Unit , 2020, Influenza and other respiratory viruses.

[13]  A. Rames,et al.  An update on the detection methods of Parachlamydia acanthamoebae, an atypical agent of pneumonia , 2019, Asia Pacific Journal of Molecular Biology and Biotechnology.

[14]  L. Mannonen,et al.  Parachlamydia acanthamoebae Detected during a Pneumonia Outbreak in Southeastern Finland, in 2017–2018 , 2019, Microorganisms.

[15]  S. Abdelkafi,et al.  A DNA Barcoding Survey of Ulva (Chlorophyta) in Tunisia and Italy Reveals the Presence of the Overlooked Alien U. ohnoi , 2018, Cryptogamie, Algologie.

[16]  Daisuke Sano,et al.  Sapovirus in Wastewater Treatment Plants in Tunisia: Prevalence, Removal, and Genetic Characterization , 2018, Applied and Environmental Microbiology.

[17]  P. Scheid,et al.  Free-Living Amoebae as Hosts for and Vectors of Intracellular Microorganisms with Public Health Significance , 2017, Viruses.

[18]  J. Stehle,et al.  Severe pneumonia due to Parachlamydia acanthamoebae following intranasal inoculation: a mice model. , 2015, Microbes and infection.

[19]  Gilbert GREUB,et al.  Lack of Chlamydia-related bacteria among patients with community-acquired pneumonia , 2015, New microbes and new infections.

[20]  Gilbert GREUB,et al.  A bovine model of a respiratory Parachlamydia acanthamoebae infection. , 2014, Pathogens and disease.

[21]  Gilbert GREUB,et al.  Importance of amoebae as a tool to isolate amoeba-resisting microorganisms and for their ecology and evolution: the Chlamydia paradigm. , 2014, Environmental microbiology reports.

[22]  Gilbert GREUB,et al.  First detection of Waddlia chondrophila in Africa using SYBR Green real-time PCR on veterinary samples. , 2013, Veterinary microbiology.

[23]  M. Landini,et al.  Development of a Broad-Range 23S rDNA Real-Time PCR Assay for the Detection and Quantification of Pathogenic Bacteria in Human Whole Blood and Plasma Specimens , 2013, BioMed research international.

[24]  A. Gervaix,et al.  Development of a New Chlamydiales-Specific Real-Time PCR and Its Application to Respiratory Clinical Samples , 2011, Journal of Clinical Microbiology.

[25]  Michael Kemp,et al.  Routine ribosomal PCR and DNA sequencing for detection and identification of bacteria. , 2010, Future microbiology.

[26]  J. Matsuo,et al.  Impact of Free-Living Amoebae on Presence of Parachlamydia acanthamoebae in the Hospital Environment and Its Survival In Vitro without Requirement for Amoebae , 2010, Journal of Clinical Microbiology.

[27]  Gilbert GREUB,et al.  Fastidious intracellular bacteria as causal agents of community-acquired pneumonia , 2010, Expert review of anti-infective therapy.

[28]  M. Kermekchiev,et al.  Direct DNA amplification from crude clinical samples using a PCR enhancer cocktail and novel mutants of Taq. , 2010, The Journal of molecular diagnostics : JMD.

[29]  S. Sayadi,et al.  Isolation, identification and characterization of a new lipolytic Pseudomonas sp., strain AHD‐1, from Tunisian soil , 2010, Environmental technology.

[30]  A. Gervaix,et al.  Development of a real-time PCR for the specific detection of Waddlia chondrophila in clinical samples , 2009, European Journal of Clinical Microbiology & Infectious Diseases.

[31]  Gilbert GREUB.  Parachlamydia acanthamoebae, an emerging agent of pneumonia. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[32]  A. Pospischil,et al.  Murine model of pneumonia caused by Parachlamydia acanthamoebae. , 2008, Microbial pathogenesis.

[33]  A. Gervaix,et al.  New Diagnostic Real-Time PCR for Specific Detection of Parachlamydia acanthamoebae DNA in Clinical Samples , 2008, Journal of Clinical Microbiology.

[34]  Gilbert GREUB,et al.  Criblamydia sequanensis, a new intracellular Chlamydiales isolated from Seine river water using amoebal co-culture. , 2006, Environmental microbiology.

[35]  Gilbert GREUB,et al.  Parachlamydia acanthamoebae enters and multiplies within pneumocytes and lung fibroblasts. , 2006, Microbes and infection.

[36]  Gilbert GREUB,et al.  Pathogenic Potential of Novel Chlamydiae and Diagnostic Approaches to Infections Due to These Obligate Intracellular Bacteria , 2006, Clinical Microbiology Reviews.

[37]  D. Corsaro,et al.  Diversity of the Parachlamydiae in the Environment , 2006, Critical reviews in microbiology.

[38]  S. Sayadi,et al.  Isolation and characterization of a novel Bacillus sp., strain YAS1, capable of transforming tyrosol under hypersaline conditions. , 2005, FEMS microbiology letters.

[39]  M. Wagner,et al.  Recovery of an environmental Chlamydia strain from activated sludge by co-cultivation with Acanthamoeba sp. , 2005, Microbiology.

[40]  C. Kaplan,et al.  Bacterial Succession in a Petroleum Land Treatment Unit , 2004, Applied and Environmental Microbiology.

[41]  D. Raoult,et al.  Parachlamydiaceae as Rare Agents of Pneumonia , 2003, Emerging infectious diseases.

[42]  M. Valassina,et al.  New parachlamydial 16S rDNA phylotypes detected in human clinical samples. , 2002, Research in microbiology.

[43]  C. Brunk,et al.  Analysis of specific bacteria from environmental samples using a quantitative polymerase chain reaction. , 2002, Current issues in molecular biology.

[44]  T. Marrie,et al.  Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia. , 2001, Emerging infectious diseases.

[45]  M. Wagner,et al.  Evidence for additional genus-level diversity of Chlamydiales in the environment. , 2001, FEMS microbiology letters.

[46]  J. Harvey.  Severe pneumonia. , 1982, British journal of hospital medicine.